AbCellera Biologics logo
AbCellera Biologics ABCL
$ 9.63 -7.85%
report update icon

Quarterly report 2026-Q3
added 11-09-2026

AbCellera Biologics Cash Conversion Cycle | ABCL

Annual Cash Conversion Cycle AbCellera Biologics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
173 202 - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
202 173 188

Quarterly Cash Conversion Cycle AbCellera Biologics

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
329 - - - 720 357 1.03 K - - - - - - - - - - - - - 23.2 43.2 5.46 - - 3.67 8.85 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.03 K 3.67 280

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer Cash Conversion Cycle Price % 24h Market Cap Country
Sesen Bio Sesen Bio
SESN
144 - 7.29 % $ 127 M usaUSA
Windtree Therapeutics Windtree Therapeutics
WINT
-145 - - $ 26.8 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
25.5 - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
-36.8 - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
-2.44 K - - $ 13 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
104 - - - russiaRussia
Brickell Biotech Brickell Biotech
BBI
26 - -5.38 % $ 6.06 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
-4.37 K - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
18.6 - - $ 5.78 B niderlandNiderland
Acasti Pharma Acasti Pharma
ACST
2.18 K - 4.01 % $ 150 M canadaCanada
Galapagos NV Galapagos NV
GLPG
67.1 - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-1.6 K - -4.36 % $ 27 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
33.4 $ 4.63 21.05 % $ 20 M israelIsrael
Lumos Pharma Lumos Pharma
LUMO
13.7 - - $ 35.3 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
9.2 - 0.52 % $ 821 M danmarkDanmark
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
158 - -23.04 % $ 26.6 M usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
136 - - $ 69.7 B britainBritain
Guardion Health Sciences Guardion Health Sciences
GHSI
160 - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
84.9 - - $ 109 M usaUSA
ImmunoGen ImmunoGen
IMGN
89.2 - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
-2.21 K - -8.77 % $ 12.4 M israelIsrael
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
-279 K - -2.99 % $ 2.47 M usaUSA